Title
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
Date Issued
01 November 2020
Access level
open access
Resource Type
journal article
Author(s)
Camprubí D.
Almuedo-Riera A.
Martí-Soler H.I.
Soriano A.
Subirà C.
Grau-Pujol B.
Krolewiecki A.
Muñoz J.
Universidad de Barcelona
Publisher(s)
Public Library of Science
Abstract
Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2.
Volume
15
Issue
11 November
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Sistema respiratorio
Farmacología, Farmacia
Scopus EID
2-s2.0-85096082702
PubMed ID
Source
PLoS ONE
ISSN of the container
19326203
Sources of information:
Directorio de Producción Científica
Scopus